Your browser doesn't support javascript.
loading
[A Case of Hepatocellular Carcinoma Evaluated as Complete Response by Combined Lenvatinib and Radiofrequency Ablation Therapy].
Iwatani, Yoshiteru; Oyama, Tadao; Yamano, Akito; Mimura, Daisuke; Yamano, Taketoshi; Yano, Yoshiko; Tanaka, Kenichi.
Affiliation
  • Iwatani Y; Dept. of Surgery, Himeji Central Hospital.
Gan To Kagaku Ryoho ; 50(1): 75-77, 2023 Jan.
Article de Ja | MEDLINE | ID: mdl-36759992
ABSTRACT
We report a case of hepatocellular carcinoma evaluated as complete response by combined lenvatinib and radiofrequency ablation therapy. A 74-year-old man visited our hospital because medical examination abdominal ultrasonography revealed a liver tumor. Abdominal MRI and CT showed a 3.3 cm tumor on the right hepatic vein in segment 7 of the liver, and hepatocellular carcinoma was diagnosed. Lenvatinib was administrated for 6 months, and laparoscopy-assisted radiofrequency ablation was performed as additional treatment. After 1 month, dynamic CT showed the disappearance of intratumoral arterial lesion enhancement and low density lesion area. The therapeutic effect was evaluated as a complete response.
Sujet(s)
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ablation par cathéter / Carcinome hépatocellulaire / Ablation par radiofréquence / Tumeurs du foie Limites: Aged / Humans / Male Langue: Ja Journal: Gan To Kagaku Ryoho Année: 2023 Type de document: Article
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ablation par cathéter / Carcinome hépatocellulaire / Ablation par radiofréquence / Tumeurs du foie Limites: Aged / Humans / Male Langue: Ja Journal: Gan To Kagaku Ryoho Année: 2023 Type de document: Article
...